# A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

Study · id `cardio:ct-nct06713239` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06713239](<https://clinicaltrials.gov/study/NCT06713239>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06713239

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT06713239. Randomized; no masking; primary purpose diagnostic. Start 2024-12-18 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT06713239, source copy `cardio:ctgov-nct06713239-2026-06-05`, retrieved 2026-10-26)
- Started: 2024-12-18 (actual) (ClinicalTrials.gov record NCT06713239, source copy `cardio:ctgov-nct06713239-2026-06-05`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06713239, source copy `cardio:ctgov-nct06713239-2026-06-05`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06713239, source copy `cardio:ctgov-nct06713239-2026-06-05`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06713239, source copy `cardio:ctgov-nct06713239-2026-06-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06713239-2026-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
- Acronym: PARAMOUNT
- Condition: Coronary Artery Disease
- Intervention (Device): Cleerly Labs and Cleerly ISCHEMIA
- Lead sponsor: Cleerly, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 5c9edef1175f35a786bb09621170bce264522e10a77eba58536efb95a6c40ba3
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
